Medigus Revenue and Competitors

Omer,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Medigus's estimated annual revenue is currently $7M per year.(i)
  • Medigus's estimated revenue per employee is $251,000

Employee Data

  • Medigus has 28 Employees.(i)
  • Medigus grew their employee count by 0% last year.

Medigus's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Medigus?

Medigus (Nasdaq: MDGS) (TASE: MDGS) is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions across medical and industrial applications. We have developed a range of micro video cameras under our micro ScoutCamâ„¢ portfolio of products, including the micro ScoutCam 1.2, which to the best of the company's knowledge, is the smallest in the world. Our innovative micro cameras are suitable for both medical and industrial applications and can be customized to meet a range of needs across both applications. We design and manufacture endoscopy and micro camera systems for some of the biggest medical and industrial companies in the world. We are also the pioneer developer of the Medigus Ultrasonic Surgical Endostapler, or MUSEâ„¢ system, a unique proprietary endoscopic device for the treatment of gastroesophageal reflux disease (GERD), one of the most common chronic diseases in the western world. The MUSEâ„¢ system, our flagship medical device, addresses the unmet need in between drug therapy and invasive surgery for the long-term treatment of GERD (gastroesophageal reflux disease), commonly referred to as acid reflux.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medigus News

2022-04-13 - Medigus to Invest in a Deep Energy Tech Company

Tel Aviv, Israel, April 13, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions...

2022-04-06 - Medigus: Polyrizon's PL-15 Found Effective Against Highly ...

Medigus: Polyrizon's PL-15 Found Effective Against Highly Transmissible SARS-CoV-2 Omicron Variant in Cell Culture Assays.

2022-03-30 - Medigus Announces Final Airworthiness Criteria Published by ...

Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, mainly in advanced medical...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.9M6530%N/A